Working… Menu
Trial record 2 of 1191 for:    MATCH screening trial

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02465060
Recruitment Status : Recruiting
First Posted : June 8, 2015
Last Update Posted : March 5, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)